Systematix Corporate Services Ltd
- Market Cap ₹ 3,588 Cr.
- Current Price ₹ 276
- High / Low ₹ 276 / 45.6
- Stock P/E 107
- Book Value ₹ 7.65
- Dividend Yield 0.04 %
- ROCE 31.4 %
- ROE 27.1 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 119% CAGR over last 5 years
Cons
- Stock is trading at 36.1 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5 | 3 | 2 | 0 | 3 | 8 | 9 | 5 | 10 | 31 | 28 | 56 | 76 | |
2 | 2 | 1 | 1 | 2 | 3 | 6 | 6 | 7 | 13 | 21 | 23 | 30 | |
Operating Profit | 2 | 1 | 0 | -1 | 1 | 4 | 3 | -1 | 3 | 18 | 7 | 33 | 46 |
OPM % | 45% | 38% | 20% | -366% | 38% | 56% | 30% | -27% | 28% | 57% | 26% | 58% | 61% |
0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 2 |
Profit before tax | 2 | 1 | -0 | -2 | 1 | 4 | -0 | -4 | 1 | 16 | 5 | 30 | 44 |
Tax % | 33% | 31% | -40% | -2% | -5% | 25% | -2% | -5% | -5% | 21% | 28% | 26% | |
1 | 1 | -0 | -2 | 1 | 3 | -0 | -4 | 1 | 12 | 4 | 22 | 34 | |
EPS in Rs | 0.09 | 0.05 | -0.00 | -0.12 | 0.05 | 0.23 | -0.03 | -0.29 | 0.08 | 0.95 | 0.30 | 1.69 | 2.59 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 11% | 0% | 6% |
Compounded Sales Growth | |
---|---|
10 Years: | 33% |
5 Years: | 45% |
3 Years: | 80% |
TTM: | 257% |
Compounded Profit Growth | |
---|---|
10 Years: | 41% |
5 Years: | 119% |
3 Years: | 176% |
TTM: | 42113% |
Stock Price CAGR | |
---|---|
10 Years: | 64% |
5 Years: | 138% |
3 Years: | 84% |
1 Year: | 453% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 11% |
3 Years: | 18% |
Last Year: | 27% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
Reserves | 22 | 23 | 23 | 21 | 22 | 25 | 45 | 41 | 42 | 54 | 57 | 79 | 86 |
28 | 25 | 28 | 29 | 28 | 37 | 17 | 20 | 22 | 22 | 21 | 20 | 29 | |
1 | 1 | 1 | 0 | 0 | 1 | 2 | 1 | 1 | 2 | 1 | 22 | 10 | |
Total Liabilities | 64 | 62 | 65 | 64 | 64 | 76 | 77 | 75 | 78 | 92 | 92 | 134 | 138 |
2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 10 | 9 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 60 | 60 | 62 | 62 | 62 | 64 | 66 | 67 | 67 | 82 | 82 | 81 | 81 |
3 | 0 | 2 | 1 | 1 | 11 | 9 | 7 | 11 | 9 | 10 | 43 | 48 | |
Total Assets | 64 | 62 | 65 | 64 | 64 | 76 | 77 | 75 | 78 | 92 | 92 | 134 | 138 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-8 | 4 | 0 | -2 | 1 | -6 | 0 | -2 | -2 | 17 | 4 | 43 | |
0 | -1 | -2 | 0 | -0 | -4 | 2 | 2 | 2 | -12 | -1 | -6 | |
8 | -3 | 2 | 2 | -1 | 10 | -3 | -0 | 0 | -3 | -4 | -3 | |
Net Cash Flow | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | 0 | 2 | -1 | 35 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 138 | 2 | 292 | 46 | 19 | 26 | 25 | 14 | 19 | 43 | 2 | 4 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 138 | 2 | 292 | 46 | 19 | 26 | 25 | 14 | 19 | 43 | 2 | 4 |
Working Capital Days | 44 | -126 | 41 | 34 | 9 | 449 | -3 | 45 | 216 | 23 | 51 | -97 |
ROCE % | 3% | 2% | 0% | -2% | 1% | 6% | 2% | -3% | 4% | 21% | 8% | 31% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov - Submission of en extract of newspaper publication regarding un-audited financial results for the quarter and half year ended September 30, 2024.
-
Announcement under Regulation 30 (LODR)-Allotment
14 Nov - Allotment of 67,35,430 equity shares to non-promoters.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
13 Nov - Systematix reports 83.33% revenue growth in H1 FY25.
-
Results - Financial Results For The Quarter And Half Year Ended September 30, 2024.
13 Nov - Approved un-audited financial results for Q2 2024.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 13, 2024
13 Nov - Approved un-audited financial results for Q2 FY2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Segments